pirfenidone has been researched along with Renal Insufficiency, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jo, YS; Kim, KJ; Kim, YH; Rhee, CK | 1 |
| He, JM; Qiu, ZZ; Yu, ZH; Zhang, HX; Zhang, ZW; Zhou, H | 1 |
| Chen, JF; Chen, PS; Liu, BC; Liu, H; Lv, LL; Ni, HF; Tang, RN; Zhang, AH; Zhang, MH | 1 |
| Boor, P; Floege, J; Goldschmeding, R; Klinkhammer, BM | 1 |
| Abramowitz, MK; Bauer, C; Hostetter, TH; Melamed, ML; Turner, JM | 1 |
| Chen, JF; Liu, BC; Liu, H; Ni, HF; Pan, MM; Xu, M; Zhang, MH | 1 |
2 review(s) available for pirfenidone and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Treatment of Renal Fibrosis-Turning Challenges into Opportunities.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Biomarkers; Connective Tissue Growth Factor; Elasticity Imaging Techniques; Endpoint Determination; Extracellular Matrix; Fibrosis; Galectin 3; Humans; Kidney; Magnetic Resonance Imaging; Polysaccharides; Pyridones; Renal Insufficiency, Chronic; Transforming Growth Factor beta | 2017 |
Treatment of chronic kidney disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diabetes Mellitus, Type 2; Disease Progression; Endothelin-1; Humans; Hypertension; Kidney Failure, Chronic; Oleanolic Acid; Pyridones; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2012 |
4 other study(ies) available for pirfenidone and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Effects of comorbid chronic kidney disease on mortality in idiopathic pulmonary fibrosis patients and influence of pirfenidone.
Topics: Comorbidity; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Pyridones; Renal Insufficiency, Chronic; Treatment Outcome | 2023 |
Renoprotective effects of pirfenidone on chronic renal allograft dysfunction by reducing renal interstitial fibrosis in a rat model.
Topics: Allografts; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Fibrosis; Graft Rejection; Kidney Transplantation; Kidney Tubules; Male; Protective Agents; Pyridones; Rats; Rats, Inbred F344; Rats, Inbred Lew; Renal Insufficiency, Chronic | 2019 |
Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Fibrosis; Humans; Kidney Tubules, Proximal; Male; Mitochondria; Nephrectomy; Nephritis, Interstitial; Pyridones; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2013 |
Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats.
Topics: Acetylglucosaminidase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Pressure; Chemokine CCL2; Chemokine CCL3; Drug Evaluation, Preclinical; Kidney; Macrophages; Male; Nephrectomy; Nephrosclerosis; Phenotype; Proteinuria; Pyridones; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2013 |